ND: |
ME09824843 |
PMID: |
9824843 |
LR: |
20041117 |
CED: |
19990217 |
DCO: |
19990217 |
Autoren: |
Russell AL |
Titel: |
Glucosamine in osteoarthritis and gastrointestinal disorders: an exemplar of the need for a paradigm shift. |
Quelle: |
Medical hypotheses; VOL: 51 (4); p. 347-9 /199810/ |
PM: |
Print |
SU: |
IM |
Sprache: |
English |
CY: |
ENGLAND |
JID: |
7505668 |
ISSN: |
0306-9877 |
CO: |
MEHYDY |
Institution: |
Brampton Pain Clinic, Bramalea, Ontario, Canada. |
DT: |
Journal Article |
Schlagwörter |
CT: |
ANIMALS; GLUCOSAMINE/pharmacology; GLUCOSAMINE/*therapeutic use; HUMANS; INFLAMMATORY BOWEL DISEASES/drug therapy; INFLAMMATORY BOWEL DISEASES/etiology; OSTEOARTHRITIS/*drug therapy; OSTEOARTHRITIS/etiology; WOUND HEALING/drug effects |
CTG: |
TIER; GLUCOSAMIN/Pharmakologie; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; ENTZÜNDLICHE DARMKRANKHEITEN/Arzneimitteltherapie; ENTZÜNDLICHE DARMKRANKHEITEN/Ätiologie; OSTEOARTHROSE/*Arzneimitteltherapie; OSTEOARTHROSE/Ätiologie; WUNDHEILUNG/Arzneimittelwirkungen |
TE: |
Glucosamine/3416-24-8 |
CR: |
3416-24-8 |
AB: |
Glucosamine, after a latent period, is rapidly developing a position in the treatment of osteoarthritis, as well as a potential therapeutic place in wound healing and gastrointestinal disorders. Although recognized for a great many years, the association of gastrointestinal disorders and arthritis has been looked on as an unexplained oddity. Could this be indicative of a common etiology in the rate-limiting production of glucosamine? Could diverse presentations and pathology be due to a common-stem biochemical defect? |